Boxer Capital Discloses 10.0% Stake in Fate Therapeutics

TL;DR

**Boxer Capital just bought 10% of FATE, big institutional vote of confidence!**

AI Summary

Boxer Capital, LLC, a Delaware-based investment firm, has disclosed a significant stake in Fate Therapeutics, Inc. (FATE), a biotechnology company. As of January 31, 2024, Boxer Capital, along with its group members including Aaron I. Davis, Boxer Asser Management Inc., Joe Lewis, and MVA Investors, LLC, beneficially owns 10,000,000 shares of FATE's common stock. This represents a 10.0% ownership stake in the company, signaling a strong conviction from a major institutional investor. This matters to current and prospective FATE shareholders because it indicates a notable vote of confidence from a sophisticated investor, potentially suggesting an expectation of future growth or value creation.

Why It Matters

A large institutional investment like this can signal confidence in the company's future prospects and potentially attract other investors, influencing stock price.

Risk Assessment

Risk Level: low — This filing indicates a significant investment by an institutional holder, which is generally seen as a positive signal, reducing perceived risk.

Analyst Insight

A smart investor would view this as a positive signal, potentially researching Fate Therapeutics further to understand what attracted Boxer Capital's significant investment, and consider if it aligns with their own investment thesis.

Key Numbers

• 10,000,000 — Shares Beneficially Owned (Total shares of Fate Therapeutics common stock owned by Boxer Capital and its group)
• 10.0% — Ownership Percentage (Percentage of Fate Therapeutics' common stock owned by Boxer Capital and its group)
• $0.001 — Par Value per Share (Par value of Fate Therapeutics' common stock)
• January 31, 2024 — Date of Event (The date requiring the filing of this statement)

Key Players & Entities

• Boxer Capital, LLC (company) — reporting person and investment firm
• Fate Therapeutics, Inc. (company) — subject company, biotechnology firm
• Aaron I. Davis (person) — group member of Boxer Capital
• Boxer Asser Management Inc. (company) — group member of Boxer Capital
• Joe Lewis (person) — group member of Boxer Capital
• MVA Investors, LLC (company) — group member of Boxer Capital
• Delaware (company) — place of organization for Boxer Capital, LLC

Forward-Looking Statements

• Boxer Capital, LLC will maintain or increase its stake in Fate Therapeutics, Inc. over the next 6-12 months. (Boxer Capital, LLC) — medium confidence, target: 2025-02-12
• Fate Therapeutics, Inc. will see increased institutional investor interest following this disclosure. (Fate Therapeutics, Inc.) — medium confidence, target: 2024-08-12

FAQ

Key Financial Figures

• $0.001 — ame of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securitie

Filing Documents

• ff3013867_13g-fate.htm (SC 13G) — 179KB
• ff3013867_13gex991-fate.htm (EX-99.1) — 14KB
• 0000895345-24-000042.txt ( ) — 194KB

(a)

Item 1. (a) Name of Issuer The name of the issuer is Fate Therapeutics, Inc. (the " Issuer ").

(b)

Item 1. (b) Address of Issuer's Principal Executive Offices The Issuer's principal executive offices are located at 12278 Scripps Summit Drive, San Diego, CA 92131 .

(a)

Item 2. (a) Name of Person Filing This Schedule 13G is jointly filed by Boxer Capital, LLC (" Boxer Capital "), Boxer Asset Management Inc. (" Boxer Management "), Joe Lewis, MVA Investors, LLC (" MVA Investors ") and Aaron I. Davis (collectively, the " Reporting Persons "). Boxer Management is the managing member and majority owner of Boxer Capital. Joe Lewis is the sole indirect beneficial owner of and controls Boxer Management. MVA Investors is the independent, personal investment vehicle of certain employees of Boxer Capital. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors.

(b)

Item 2. (b) Address of Principal Business Office or, if None, Residence The principal business address of Boxer Capital, MVA Investors and Aaron I. Davis is: 12860 El Camino Real, Suite 300, San Diego, CA 92130. The principal business address of Boxer Management and Joe Lewis is: Cay House, EP Taylor Drive N7776, Lyford Cay, New Providence, Bahamas.

(c)

Item 2. (c) Citizenship Boxer Capital and MVA Investors are limited liability companies organized under the laws of Delaware. Boxer Management is a corporation organized under the laws of the Bahamas. Joe Lewis is a citizen of the United Kingdom. Aaron I. Davis is a citizen of the United States of America.

(d)

Item 2. (d) Title of Class of Securities Common Stock, $0.001 par value per share (" Common Stock ").

(e)

Item 2. (e) CUSIP Number The CUSIP number for the Common Stock is 31189P102. Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: Not Applicable. Item 4. (a) Amount beneficially owned: Boxer Capital, Boxer Management and Joe Lewis beneficially own 6,171,000 shares of Common Stock. MVA Investors and Aaron I. Davis beneficially own 290,000 shares of Common Stock. The Reporting Persons beneficially own, in the aggregate, 6,461,000 shares of Common Stock. (b) Percent of class: All percentages of beneficial ownership set forth herein are based on 98,601,966 shares of Common Stock reported outstanding on October 31, 2023 in the Quarterly Report on Form 10-Q filed by the Issuer with the Securities and Exchange Commission on November 8, 2023. The number of shares of Common Stock beneficially owned by the Reporting Persons in the aggregate represent 6.6% of the Issuer's outstanding shares of Common Stock. (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: None of the Reporting Persons has sole power to vote or to direct the vote of any shares of Common Stock. (ii) Shared power to vote or to direct the vote: Boxer Capital, Boxer Management and Joe Lewis have shared power to vote or to direct the vote of 6,171,000 shares of Common Stock. MVA Investors and Aaron I. Davis have shared power to vote or to direct the vote of 290,000 shares of Common Stock. (iii) Sole power to dispose or to direct the disposition of: None of the Reporting Persons has sole power to dispose or to direct the disposition of any shares of Common Stock. (iv) Shared power to dispose or to direct the disposition of: Boxer Capital, Boxer Management and Joe Lewis have shared power to dispose or to direct the disposition of 6,171,000 shares of Common Stock. MVA Investors and Aaron I. Davis have shared power to dispose or to direct the disposition of 290,000 s

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 12, 2024 BOXER CAPITAL, LLC By: /s/ Aaron I. Davis Name: Aaron I. Davis Title: Authorized Signatory BOXER ASSET MANAGEMENT INC. By: /s/ Paul Higgs Name: Paul Higgs Title: Director JOSEPH C. LEWIS /s/ Joseph C. Lewis Joseph C. Lewis, Individually MVA INVESTORS, LLC By: /s/ Aaron I. Davis Name: Aaron I. Davis Title: Authorized Signatory AARON I. DAVIS /s/ Aaron I. Davis Aaron I. Davis, Individually

View Full Filing

View this SC 13G filing on SEC EDGAR